Toolkit/channelrhodopsin-2

channelrhodopsin-2

Multi-Component Switch·Research·Since 2009

Also known as: channelrhodopsin-2, Channelrhodopsin-2, Channelrhodopsin2, channelrhodopsin-2 (ChR2), Channelrhodopsin-2 (ChR2), channelrhodopsin protein ChR2, ChR2, FLEX-ChR2, highly light-sensitive channelrhodopsin-2 mutant, optogenetic seizure-like afterdischarge model

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Channelrhodopsin-2 (ChR2) is a light-activated ion channel used as an optogenetic switch to depolarize membranes and activate electrically excitable cells. The supplied evidence also indicates that light-activated ChR2 can modulate CaV1.3 calcium channel activity.

Usefulness & Problems

Why this is useful

ChR2 is useful for optical control of membrane voltage in excitable cells, enabling noninvasive activation with light rather than direct electrical stimulation. The evidence places it as a prominent optogenetic actuator and as one of the classical mechanisms for optical cell activation.

Source:

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels

Source:

present successful applications to light-control gene expression with single or combined photoswitches in plants

Source:

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.

Source:

the C128T mutant, which has a markedly increased open-state lifetime

Problem solved

ChR2 helps solve the problem of triggering membrane depolarization and activation of electrically excitable cells with precise light input. The evidence further suggests utility for coupling light stimulation to downstream voltage-dependent processes such as CaV1.3 channel modulation.

Source:

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels

Source:

present successful applications to light-control gene expression with single or combined photoswitches in plants

Source:

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

Source:

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument

Published Workflows

Objective: Validate common viral serotypes for identifying and analyzing Sp5C projection neurons that project to the parabrachial nucleus and demonstrate selective genetic access to this population.

Why it works: The workflow uses injections into the projection target, the parabrachial nucleus, so neurons projecting there can be retrogradely labeled and then assessed for labeling pattern and transduction utility. A subsequent Cre-dependent recombination demonstration tests whether the labeled projection class can be selectively accessed for future functional studies.

retrograde transduction of parabrachial-projecting Sp5C neuronsCre-dependent recombination for selective effector expressionviral serotype comparisonretrograde circuit labelingprojection-targeted genetic access

Stages

  1. 1.
    Retrograde viral labeling of PBN-projecting Sp5C neurons(broad_screen)

    This stage tests whether the two viral serotypes can identify and label Sp5C neurons that project to the parabrachial nucleus.

    Selection: Ability of rgAAV or AAV9 injected into the PBN to retrogradely label Sp5C projection neurons.

  2. 2.
    Comparative characterization of labeling pattern(secondary_characterization)

    This stage characterizes how labeling is distributed and whether performance differs by serotype, region, or age.

    Selection: Bilateral versus ipsilateral-biased labeling, superficial versus deep Sp5C labeling, and age dependence of retrograde labeling.

  3. 3.
    Selective Cre-dependent effector expression in labeled projection neurons(confirmatory_validation)

    This stage confirms that the projection-neuron population can be selectively targeted with a functional effector after viral labeling logic is established.

    Selection: Successful Cre-dependent recombination to selectively express channelrhodopsin-2 in Sp5C projection neurons.

Steps

  1. 1.
    Inject rgAAV or AAV9 unilaterally into the parabrachial nucleusretrograde viral labeling vectors

    Target the projection field so Sp5C neurons projecting to the PBN can be retrogradely labeled.

    Injection into the target region is required before labeled projection neurons can be identified and compared.

  2. 2.
    Assess labeling distribution and compare serotype and age effectsvectors being compared

    Determine whether labeling is bilateral or ipsilateral-biased, whether superficial and deep Sp5C are similarly labeled, and whether labeling depends on age at injection.

    Characterization follows labeling so the utility and context dependence of each serotype can be evaluated before claiming suitability for future studies.

  3. 3.
    Demonstrate Cre-dependent recombination for selective channelrhodopsin-2 expression in Sp5C projection neuronsselectively expressed effector

    Confirm that the projection-neuron population can be selectively targeted for future functional studies.

    Selective effector expression is tested after establishing that the projection-neuron population can be robustly labeled and analyzed.

Objective: Develop an all-optical cardiac electrophysiology approach that simultaneously monitors transmembrane potential and cytosolic calcium while enabling optogenetic manipulation with minimal optical crosstalk.

Why it works: The abstract states that spectral congestion causes crosstalk, and that the reported approach minimizes this by exploiting the isosbestic point of ElectroFluor 730p while avoiding the ChR2 activation spectrum.

exploiting the isosbestic point of ElectroFluor 730pavoiding the ChR2 activation spectrumcareful spectral selection of optogenetic proteins and fluorescent dyescombined optical imaging and optogenetic manipulation

Objective: Implement cardiac optogenetic experiments by selecting an appropriate opsin class, establishing expression in the target cardiac system, delivering light effectively, and measuring physiological or optical responses.

Why it works: The review links tool performance first to opsin biophysical properties, then to successful expression in the cardiac target, then to practical light delivery, and finally to physiological or optical readout. This ordering reflects that optical control requires both a suitable actuator and a feasible delivery-and-measurement setup.

light-gated transmembrane ion movementdepolarizationhyperpolarizationG-protein coupled intracellular signaling modulationopsin selectionviral transductionspark-cell couplingtransgenic expressionin vivo adenoviral deliverylaser illuminationLED illuminationelectrophysiological readoutoptical readout

Stages

  1. 1.
    Select optogenetic actuator class and spectral properties(library_design)

    The abstract explicitly states that opsin biophysical properties determine whether stimulation or silencing will be reliable and precise, and that spectral shifts can improve penetration and combinatorial use.

    Selection: Choose among depolarizing, hyperpolarizing, GPCR-signaling, and spectrally shifted optogenetic tools based on biophysical properties needed for reliable and precise stimulation or silencing.

  2. 2.
    Establish expression in the cardiac target(library_build)

    The review states that expression of the chosen optogenetic tool is required before optical control can be attempted in cardiac cells or whole systems.

    Selection: Introduce opsin-encoding genes by viral transduction or use spark-cell coupling at single-cell level; at system level use transgenic mice or in vivo adenoviral injection.

  3. 3.
    Deliver light to the preparation(functional_characterization)

    Even with a suitable opsin and expression strategy, optical control depends on practical light delivery to the cardiac tissue.

    Selection: Use laser or LED illumination with widespread or multipoint delivery appropriate to the preparation.

  4. 4.
    Measure physiological or optical responses(confirmatory_validation)

    The abstract presents these readouts as the means to confirm and monitor the effects of cardiac optogenetic stimulation.

    Selection: Assess responses using patch clamp, multi-unit microarray recordings, Langendorff heart electrical recordings, or optical reporters including small detecting molecules and genetically encoded sensors.

Objective: Develop and demonstrate a wireless, battery-free, fully implantable pacemaker platform for small animal models that supports multimodal and multisite cardiac stimulation.

Why it works: The platform combines wireless energy harvesting and digital communication electronics with implanted stimulation interfaces, enabling battery-free pacing while supporting both electrical and optical modalities.

electrical cardiac stimulationoptical cardiac stimulationwireless energy harvestingdigital communicationimplantable device engineering

Objective: Restore light responsiveness in degenerated retina while using stimulation intensities compatible with retinal safety and assess translatability across mouse, macaque, and human retinal systems.

Why it works: The abstract states that blue-light activation of ChR2 exceeds retinal safety thresholds, whereas red-shifted light has much lower damage potential. The workflow therefore uses a red-shifted channelrhodopsin and tests function in progressively more translational retinal systems.

red-shifted optogenetic activation of retinal circuitry downstream of photoreceptorsAAV-mediated gene deliverylentiviral gene deliveryoptogenetic stimulation

Stages

  1. 1.
    Actuator and delivery choice based on retinal safety rationale(decision_gate)

    This stage exists to choose an optogenetic strategy compatible with retinal safety constraints before testing restoration.

    Selection: Prefer a red-shifted channelrhodopsin over ChR2 because blue-light activation of ChR2 exceeds retinal safety thresholds and red-shifted light has lower damage potential.

  2. 2.
    Blind mouse functional restoration testing(confirmatory_validation)

    This stage establishes proof of functional restoration in a blind animal model.

    Selection: Test whether AAV-delivered ReaChR restores light responses in blind rd1 mice at retinal, cortical, and behavioral levels under orange light below the human retinal safety threshold.

  3. 3.
    Macaque retina translatability testing(confirmatory_validation)

    This stage extends the findings from mouse to primate retinal tissue.

    Selection: Test whether AAV-ReaChR can evoke spike trains in postmortem macaque retina at safe orange-light intensities.

  4. 4.
    Human retina translatability testing(confirmatory_validation)

    This stage directly addresses translatability to human subjects.

    Selection: Directly test translatability to human subjects by measuring optogenetic spike responses in ganglion cells of postmortem human retina after AAV- or lentivirus-mediated delivery.

Objective: Test whether selective optogenetic activation of VTA dopamine neurons is sufficient to induce arousal and reanimation from an anesthetized unconscious state.

Why it works: The workflow combines cell-type-targeted ChR2 expression in DAT-cre mice with optical VTA stimulation to test causal sufficiency, then uses a no-ChR2 control and D1 receptor antagonist pretreatment to distinguish opsin-dependent and receptor-dependent effects.

selective stimulation of VTA dopamine neuronsdopamine D1 receptor-dependent arousal signalingCre-dependent optogeneticsoptical stimulationbehavioral righting assayEEG monitoringpharmacologic antagonism

Objective: Test whether optogenetic defibrillation using cardiac ChR2 expression can terminate ventricular arrhythmias in mouse hearts and assess translational feasibility in human heart simulations.

Why it works: The workflow combines optical actuation in ChR2-expressing cardiac tissue with mechanistic and simulation analyses because illumination-induced transmural depolarization is proposed to block Na+ channel availability and interrupt arrhythmia wavefront propagation.

ChR2-mediated transmural depolarization of myocardiumblock of voltage-dependent Na+ channels throughout the myocardial wallinterruption of wavefront propagation into illuminated tissuetransgenic expressionAAV-based gene transferepicardial illuminationin silico simulation of infarct-related ventricular tachycardia

Objective: Control seizure activity using optogenetic interventions selected by target cell type, circuit location, and intervention timing.

Why it works: The supplied evidence indicates that seizure-control strategies are organized across focal targets, cell types, and closed-loop paradigms, implying that intervention efficacy depends on matching optical control mode and timing to the relevant seizure network.

neuronal inhibitionneuronal activationclosed-loop on-demand interventionoptogeneticsreal-time seizure detection

Objective: Characterize optogenetic stimulation of spiral ganglion neurons as a strategy to activate the auditory pathway and improve frequency resolution relative to electrical cochlear stimulation in rodents.

Why it works: The abstract states that optical stimulation can be spatially confined, which may improve frequency resolution compared with electrical stimulation that suffers from broad current spread within the cochlea.

optical activation of neurons expressing channelrhodopsin-2spatially confined cochlear stimulationvirus-mediated opsin expressionelectrophysiological recordingcomparative optical versus electrical stimulation

Stages

  1. 1.
    Initial functional characterization of optogenetic SGN stimulation(functional_characterization)

    This stage establishes that light stimulation of ChR2-expressing SGNs can drive auditory pathway responses before broader translational comparisons.

    Selection: Ability of optogenetic stimulation of SGNs to activate the auditory pathway as measured by single-neuron and population recordings.

  2. 2.
    Validation in deaf mice(confirmatory_validation)

    This stage tests whether the optogenetic strategy remains effective in a deaf condition relevant to hearing restoration.

    Selection: Restoration of auditory activity in a deaf mouse model.

  3. 3.
    Comparative spatial spread and frequency-resolution assessment(secondary_characterization)

    This stage compares optical stimulation against electrical stimulation to test the proposed advantage of spatial confinement and improved frequency resolution.

    Selection: Approximation of spatial spread of cochlear excitation using inferior colliculus LFP recordings under optical, acoustic, and electrical stimulation.

  4. 4.
    Opsin sensitivity optimization by virus-mediated variant expression(functional_characterization)

    This stage improves the optogenetic actuator to lower required light and increase usable stimulation frequency.

    Selection: Reduced light requirement and support for neuronal spiking up to 60 Hz after expression of a more light-sensitive ChR2 variant in SGNs.

Objective: Develop and apply an in vivo optogenetic seizure-like afterdischarge model to investigate directional network dynamics along the septo-temporal axis of hippocampus.

Why it works: The workflow combines controlled optical induction of afterdischarges with simultaneous electrophysiological recording and downstream network analysis, allowing seizure-like events to be reproducibly evoked and directionality along the hippocampal septo-temporal axis to be measured.

optogenetic activation of ChR2-expressing hippocampal neuronssepto-temporal hippocampal interactions during seizure initiation and terminationphotostimulationLFP recordingc-Fos stainingGranger causality analysisstate-space analysis

Stages

  1. 1.
    Establish ChR2 expression platform for hippocampal photostimulation(library_build)

    This stage provides the optogenetic actuator needed for seizure-like afterdischarge induction.

    Selection: Use either W-TChR2V4 transgenic rats or wild-type rats transfected with AAV vectors carrying ChR2 to enable hippocampal photostimulation.

  2. 2.
    Photostimulation-based induction of seizure-like afterdischarges(broad_screen)

    This stage establishes the in vivo seizure-like afterdischarge model and identifies effective stimulation parameters.

    Selection: Apply repetitive pulse photostimulation and identify conditions that induce seizure-like afterdischarges.

  3. 3.
    Secondary characterization of induction parameters and activation extent(secondary_characterization)

    This stage refines the induction conditions and confirms that the induced event engages the hippocampal network broadly enough for downstream network-dynamics analysis.

    Selection: Characterize optimal pulse frequency and duty ratio and confirm neuronal activation across the hippocampus by c-Fos staining.

  4. 4.
    Functional characterization of septo-temporal network dynamics(functional_characterization)

    This stage extracts the main mechanistic insight about longitudinal hippocampal network dynamics during seizure initiation and termination.

    Selection: Record LFPs along the septo-temporal axis and analyze causality and coherence during seizure-like afterdischarges.

Steps

  1. 1.
    Obtain hippocampal ChR2 expression in rodentsdelivery route for optogenetic actuator expression

    Enable optical activation of hippocampal neurons for seizure-like afterdischarge induction.

    ChR2 expression is required before photostimulation can be used to induce afterdischarges.

  2. 2.
    Apply repetitive pulse photostimulation while recording LFPsinduced seizure model

    Induce seizure-like afterdischarges and observe them electrophysiologically.

    After ChR2 expression is established, photostimulation is used to test whether the model can reliably evoke afterdischarges.

  3. 3.
    Identify effective stimulation parameters and confirm whole-hippocampus activation by c-Fos staininginduced seizure model under characterization

    Determine optimal induction settings and verify that the induced event activates the hippocampal network broadly.

    Parameter optimization and activation confirmation strengthen interpretation before detailed network-dynamics analysis.

  4. 4.
    Analyze septo-temporal LFP recordings with Granger causality and state-space methodsnetwork-analysis method

    Infer directional signal flow and identify dynamical states during seizure-like afterdischarges.

    This analysis depends on having induced afterdischarges and recorded LFPs along the septo-temporal axis.

Objective: Probe how matrix thalamic inputs influence layer 1 circuits in mouse prefrontal cortex and test whether matrix thalamocortical systems share or differ from established core sensory thalamocortical synaptic and circuit mechanisms.

Why it works: Expressing Channelrhodopsin-2 in matrix thalamic neurons allows optical activation of their L1-projecting axons, while in vitro electrophysiology reads out synaptic and circuit responses in prefrontal cortex.

thalamocortical transmission to layer 1preferential recruitment of layer 1 inhibitory interneuronsfeedforward inhibition onto layer 1 interneurons and layer 2/3 pyramidal cellsoptogenetic activationin vitro electrophysiology

Objective: Test whether transient optogenetic activation of genetically targeted VTA dopamine neurons is sufficient to act as a reward signal and reinforce behavior.

Why it works: The study uses ChR2-mediated optical stimulation to reproduce the brief approximately 200 ms activation pattern associated with natural reward events, allowing direct causal testing of whether that transient is sufficient for reinforcement.

mimic natural reward-associated transient dopamine-neuron activationtest whether transient dopamine activation functions as a reward signal that drives learninggenetic targeting of VTA dopamine neuronsoptical stimulationbehavioral testing

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Techniques

No technique tags yet.

Target processes

recombinationsignaling

Input: Light

Implementation Constraints

The evidence supports heterologous expression as an implementation approach and indicates that retinal availability can be a practical issue in plant systems. Beyond these points, the supplied material does not provide construct architecture, promoter choices, trafficking elements, or delivery details.

The provided evidence does not report quantitative performance metrics such as conductance, kinetics, spectral peak, or photocurrent amplitude for this specific profile. A cited plant optogenetics review notes that dependence on light and absence of retinal were barriers in plants, indicating practical constraints for some biological contexts.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Observations

successMouseapplication demomouse

Inferred from claim c4 during normalization. A combination of ElectroFluor 730p, X-Rhod-1, and ChR2 in mouse hearts enables simultaneous monitoring of transmembrane potential and cytosolic calcium while performing optogenetic manipulation with minimal crosstalk. Derived from claim c4. Quoted text: We here present a novel approach to simultaneously monitor transmembrane potential and cytosolic calcium, while also performing optogenetic manipulation. For this, we used the novel voltage-sensitive dye ElectroFluor 730p and the cytosolic calcium indicator X-Rhod-1 in mouse hearts expressing channelrhodopsin-2 (ChR2). By exploiting the isosbestic point of ElectroFluor 730p and avoiding the ChR2 activation spectrum, we here introduce a novel optical imaging and manipulation approach with minimal crosstalk.

Source:

successMouseapplication demomouse

behavioral and EEG

Inferred from claim c1 during normalization. Selective optogenetic activation of VTA dopamine neurons is sufficient to induce arousal from an anesthetized unconscious state during steady-state isoflurane anesthesia. Derived from claim c1.

Source:

righting restoration(6/6 mice)
successMouseapplication demomouse

Inferred from claim c2 during normalization. Optogenetic stimulation of spiral ganglion neurons restored auditory activity in deaf mice. Derived from claim c2. Quoted text: Furthermore, optogenetic stimulation of SGNs restored auditory activity in deaf mice.

Source:

successMouseapplication demomouse

operant reinforcement

Inferred from claim c2 during normalization. A single 200 ms light pulse delivered after each self-initiated nose poke was sufficient to cause operant reinforcement. Derived from claim c2. Quoted text: When a single light pulse followed each self-initiated nose poke, it was sufficient in itself to cause operant reinforcement.

Source:

successMouseapplication demomouse

locomotor behavior

Inferred from claim c3 during normalization. Optical stimulation of genetically targeted VTA dopamine neurons increased locomotion and contralateral rotations when delivered according to a predetermined pattern in separate sessions. Derived from claim c3. Quoted text: when optical stimulation was delivered in separate sessions according to a predetermined pattern, it increased locomotion and contralateral rotations

Source:

Supporting Sources

Ranked Claims

Claim 1age dependencesupports2025Source 2needs review

Retrograde labeling of Sp5C projection neurons was greater when injections were made in young adult animals.

Claim 2clinical milestone summarysupports2025Source 11needs review

A key milestone described by the review is partial vision restoration in a human patient using ChrimsonR with light-amplifying goggles.

Claim 3comparative observationsupports2025Source 2needs review

Within Sp5C, rgAAV and AAV9 produced similar levels of projection-neuron labeling in superficial and deep regions.

Claim 4comparative property summarysupports2025Source 11needs review

Red-shifted opsins including ReaChR and ChrimsonR reduce phototoxicity by enabling activation under longer wavelengths.

Claim 5distribution observationsupports2025Source 2needs review

For both serotypes, labeled Sp5C projection neurons were found bilaterally with a strong ipsilateral bias.

Claim 6genetic access demosupports2025Source 2needs review

Cre-dependent recombination successfully enabled selective channelrhodopsin-2 expression in Sp5C projection neurons.

Claim 7overall conclusionsupports2025Source 2needs review

rgAAV and AAV9 produce strong Sp5C projection-neuron transduction and provide a basis for future study of Sp5C projection-neuron afferent and efferent functions.

Claim 8performance observationsupports2025Source 2needs review

Following unilateral PBN injections, both rgAAV and AAV9 retrogradely labeled many Sp5C projection neurons.

Claim 9performance summarysupports2025Source 11needs review

Chronos provides superior temporal kinetics for dynamic visual tracking.

Claim 10performance summarysupports2025Source 11needs review

MCO1 optimized opsin performance under ambient light, helping bridge optogenetic vision restoration toward real-world applications.

Claim 11utility validationsupports2025Source 2needs review

rgAAV and AAV9 were evaluated as viral serotypes for identifying and analyzing Sp5C projection neurons that project to the parabrachial nucleus.

Claim 12adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 13adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 14adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 15adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 16adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 17adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 18adoption barriersupports2023Source 17needs review

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.
Claim 19applicationsupports2023Source 35needs review

A combination of ElectroFluor 730p, X-Rhod-1, and ChR2 in mouse hearts enables simultaneous monitoring of transmembrane potential and cytosolic calcium while performing optogenetic manipulation with minimal crosstalk.

We here present a novel approach to simultaneously monitor transmembrane potential and cytosolic calcium, while also performing optogenetic manipulation. For this, we used the novel voltage-sensitive dye ElectroFluor 730p and the cytosolic calcium indicator X-Rhod-1 in mouse hearts expressing channelrhodopsin-2 (ChR2). By exploiting the isosbestic point of ElectroFluor 730p and avoiding the ChR2 activation spectrum, we here introduce a novel optical imaging and manipulation approach with minimal crosstalk.
Claim 20application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 21application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 22application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 23application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 24application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 25application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 26application summarysupports2023Source 17needs review

Recent work has used green light-gated ion channels to control plant growth and cellular motion.

We summarize the recent results of work in the field to control plant growth and cellular motion via green light-gated ion channels
Claim 27application summarysupports2023Source 17needs review

Single or combined photoswitches have been successfully applied for light-controlled gene expression in plants.

present successful applications to light-control gene expression with single or combined photoswitches in plants
Claim 28capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 29capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 30capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 31capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 32capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 33capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 34capability summarysupports2023Source 17needs review

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.
Claim 35field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 36field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 37field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 38field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 39field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 40field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 41field adoption summarysupports2023Source 17needs review

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants
Claim 42review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 43review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 44review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 45review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 46review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 47review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 48review scope summarysupports2023Source 17needs review

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.
Claim 49capability summarysupports2022Source 5needs review

Channelrhodopsin-2 is described as enabling millisecond neuromodulation.

Since the first demonstration of the millisecond neuromodulation ability of the channelrhodopsin-2 (ChR2)
Claim 50field progress summarysupports2022Source 5needs review

Optogenetic technology progressed rapidly in basic life science research, especially neurobiology, after the first demonstration of ChR2-based millisecond neuromodulation.

the application of optogenetic technology in basic life science research has been rapidly progressed, especially in neurobiology
Claim 51advantage summarysupports2021Source 4needs review

Channelrhodopsin-2-based optogenetic approaches can offer low-energy and localized control.

Claim 52foundational usesupports2021Source 19needs review

ChR2 expression in retinal ganglion cells of blind mice served as an early feasibility demonstration for optogenetic vision restoration.

Our first demonstration of the feasibility of such an approach involved expressing ChR2 in the retinal ganglion cells of blind mice
Claim 53technology development summarysupports2021Source 4needs review

Implantable optical devices are being extensively developed for studying cardiac electrophysiological phenomena with precise optogenetic control.

Claim 54translation barrier summarysupports2021Source 4needs review

Translation of implantable optogenetic technology toward clinical cardiovascular applications remains difficult and requires potential solutions.

Claim 55application summarysupports2020Source 14needs review

These reviewed tools serve as powerful technical means to explore mechanisms underlying disease models and to evaluate drug effects in neuroscience.

Claim 56capability summarysupports2020Source 14needs review

CLARITY technology and optogenetics can be used to visualize neuronal circuits in whole-brain samples.

Claim 57capability summarysupports2020Source 14needs review

Tracer-based magnetic resonance imaging can be used to visualize the interstitial system of the brain.

Claim 58review scope summarysupports2020Source 14needs review

The review covers MALDI time-of-flight mass spectrometry imaging, tracer-based MRI, CLARITY technology, and optogenetics as CNS study tools.

Claim 59advantage summarysupports2019Source 34needs review

Spectrally shifted opsin variants can support enhanced tissue penetration, combinatorial stimulation of different cell subpopulations, and all-optical read-in and read-out studies.

Claim 60application resultsupports2019Source 43needs review

The paper includes biocompatibility characterization of the implant platform.

Claim 61application resultsupports2019Source 43needs review

The paper reports chronic rat pacing for up to 6 days.

pacing duration 6 days
Claim 62application resultsupports2019Source 43needs review

The paper reports ex vivo optogenetic pacing in ChR2 hearts.

Claim 63application summarysupports2019Source 34needs review

In cardiac physiology, optogenetics has mainly used optically controlled depolarizing ion channels to control heart rate and for optogenetic defibrillation.

Claim 64assay summarysupports2019Source 34needs review

Cardiac optogenetic stimulation can be read out using patch clamp, multi-unit microarray recordings, Langendorff heart electrical recordings, and optical reporters including small detecting molecules or genetically encoded sensors.

Claim 65capability summarysupports2019Source 34needs review

Optogenetic techniques use genetically expressed light-gated microbial channels or pumps to modulate cellular excitability with millisecond precision.

Claim 66comparative advantagesupports2019Source 41needs review

Cochlear optogenetics and optical cochlear implant work are framed around improved spectral selectivity relative to electrical cochlear implants.

The anchor article ... sits in the cochlear optogenetics / optical cochlear implant literature centered on spiral ganglion neuron (SGN) stimulation for improved spectral selectivity over electrical cochlear implants.
Claim 67compatibility summarysupports2019Source 34needs review

ChR2-expressing cardiomyocytes show normal baseline and active excitable membrane and Ca2+ signaling properties and are sensitive even to approximately 1 ms light pulses.

light pulse sensitivity 1 ms
Claim 68delivery requirementsupports2019Source 34needs review

Expression of the chosen optogenetic tool in cardiac cells requires gene introduction by viral transduction or coupling via spark cells at the single-cell level, and transgenic expression or in vivo adenoviral delivery at system level.

Claim 69implementation constraintsupports2019Source 34needs review

Light delivery by laser or LED is relatively straightforward in vitro but is challenged in cardiac tissue by motion and light scattering.

Claim 70modality summarysupports2019Source 15needs review

The review includes caged compounds, photoswitchable tethered ligands, and engineered light-sensitive receptors or channels as optical control modalities.

The review explicitly spans optogenetics and optopharmacology/photopharmacology for neuronal ion channels and neurotransmitter receptors, including caged compounds, photoswitchable tethered ligands, and engineered light-sensitive receptors/channels.
Claim 71selection principlesupports2019Source 34needs review

Biophysical properties of microbial opsins determine their ability to evoke reliable and precise stimulation or silencing of electrophysiological activity.

Claim 72tool capabilitysupports2019Source 43needs review

The implant platform includes wireless energy-harvesting and digital communication electronics for battery-free operation.

Claim 73tool capabilitysupports2019Source 43needs review

The implant platform supports both electrical and optical stimulation.

Claim 74tool capabilitysupports2019Source 43needs review

The paper presents wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal models.

Claim 75toolkit landscapesupports2019Source 15needs review

Named platforms aligned with the review's scope include LiGluR, LiGluN, LimGluR, optogating, ChR2, and Arch.

Primary papers for specific photoswitchable receptor platforms explicitly named in or strongly aligned with the review (LiGluR, LiGluN, LimGluR, optogating of P2X2)... Channelrhodopsin-2 (ChR2)... Arch.
Claim 76comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 77comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 78comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 79comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 80comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 81comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 82comparative structural inferencesupports2017Source 38needs review

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.
Claim 83functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 84functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 85functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 86functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 87functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 88functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 89functional effectsupports2017Source 38needs review

The ChR2 C128T mutant has a markedly increased open-state lifetime.

the C128T mutant, which has a markedly increased open-state lifetime
Claim 90structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 91structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 92structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 93structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 94structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 95structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 96structural mechanismsupports2017Source 38needs review

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.
Claim 97structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 98structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 99structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 100structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 101structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 102structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 103structural mechanismsupports2017Source 38needs review

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.
Claim 104structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 105structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 106structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 107structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 108structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 109structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 110structural mechanismsupports2017Source 38needs review

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.
Claim 111structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 112structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 113structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 114structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 115structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 116structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 117structural observationsupports2017Source 38needs review

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant
Claim 118tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 119tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 120tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 121tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 122tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 123tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 124tool rolesupports2017Source 38needs review

Channelrhodopsin 2 is a major optogenetic tool.

The light-gated ion channel channelrhodopsin 2 (ChR2) from Chlamydomonas reinhardtii is a major optogenetic tool.
Claim 125application effectsupports2016Source 22needs review

Optogenetic defibrillation using cardiac ChR2 expression effectively terminated ventricular arrhythmias in mouse hearts.

Claim 126application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 127application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 128application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 129application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 130application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 131application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 132application scopesupports2016Source 6needs review

Combining channelrhodopsin-2 with halorhodopsin enables multimodal remote control of neuronal cells in culture, tissue, and living animals.

The combination of ChR2 with hyperpolarizing-light-driven ion pumps such as the Cl(-) pump halorhodopsin (NpHR) enables multimodal remote control of neuronal cells in culture, tissue, and living animals.
Claim 133application scopesupports2016Source 12needs review

New genetically encoded tools have been applied to feeding circuits that regulate appetite.

This chapter reviews the application of new genetically encoded tools in feeding circuits that regulate appetite.
Claim 134causal rolesupports2016Source 12needs review

Rapid activation and inhibition of AgRP neurons established a causal role for rapid control of food intake.

Rapid activation and inhibition of agouti related peptide (AgRP) neurons conclusively established a causal role for rapid control of food intake.
Claim 135comparative advantagesupports2016Source 12needs review

Chemogenetic activation of AgRP neurons using hM3Dq avoids the invasive protocols required for ChR2 activation.

Chemogenetic activation of AgRP neurons using hM3Dq avoids the invasive protocols required for ChR2 activation.
Claim 136control resultsupports2016Source 20needs review

Optical VTA stimulation does not restore righting or produce EEG changes in control DAT-cre mice targeted with a viral vector lacking ChR2 during steady-state isoflurane anesthesia.

absence of righting restoration and EEG changes 5/5 mice
Claim 137delivery enabled applicationsupports2016Source 22needs review

AAV-based gene transfer of ChR2 enabled effective optogenetic termination of ventricular arrhythmias in WT mouse hearts.

Claim 138mechanismsupports2016Source 20needs review

D1 receptor antagonist pretreatment inhibits the arousal and righting-restoration effects of optical stimulation of VTA dopamine neurons during isoflurane anesthesia.

inhibition of arousal responses and righting restoration 6/6 mice
Claim 139mechanism of actionsupports2016Source 22needs review

Ventricular tachycardia termination was attributed to ChR2-mediated transmural depolarization that blocks voltage-dependent Na+ channels throughout the myocardial wall and interrupts wavefront propagation into illuminated tissue.

Claim 140mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 141mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 142mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 143mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 144mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 145mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 146mechanism summarysupports2016Source 6needs review

Channelrhodopsin-2 enables activation of electrically excitable cells through light-dependent depolarization.

The most prominent example is channelrhodopsin-2 (ChR2), which allows the activation of electrically excitable cells via light-dependent depolarization.
Claim 147mechanistic propertysupports2016Source 12needs review

ChR2 distributes into axons, enabling selective optogenetic activation of AgRP neuron axon projection fields in distinct brain areas to examine their contribution to feeding behavior.

ChR2 distributes into axons, and selective optogenetic activation of AgRP neuron axon projection fields in distinct brain areas was used to examine their individual contribution to feeding behavior.
Claim 148simulation resultsupports2016Source 22needs review

In diseased ChR2-expressing human heart simulations, red light effectively terminated ventricular tachycardia.

Claim 149sufficiencysupports2016Source 20needs review

Selective optogenetic activation of VTA dopamine neurons is sufficient to induce arousal from an anesthetized unconscious state during steady-state isoflurane anesthesia.

righting restoration 6/6 mice
Claim 150tool applicationsupports2016Source 30needs review

GCaMP6s is used in the review context as an activity reporter example for zebrafish brain imaging.

The anchor figure caption explicitly cites GCaMP6s for zebrafish brain activity imaging.
Claim 151tool applicationsupports2016Source 30needs review

LOVpep and ePDZ are presented in the review context as a light-induced intracellular trafficking control system.

The anchor figure caption names LOVpep and ePDZ in a light-induced trafficking example.
Claim 152tool composition or rolesupports2016Source 30needs review

Optopatch is presented in the review context as an all-optical electrophysiology system with CheRiff and QuasAr2 as named components.

PubMed figure captions ... explicitly mention tool/component names used in the review, especially Optopatch/CheRiff/QuasAr2.
Claim 153tooling landscapesupports2016Source 16needs review

The review context includes inhibitory opsins, excitatory opsins, closed-loop seizure detection, and luminopsin-based approaches as relevant seizure-control tools or components.

Explicitly supported component/tool names found in these sources include NpHR, ChR2, ArchT, closed-loop real-time seizure detection, and inhibitory luminopsins.
Claim 154tool mechanismsupports2016Source 30needs review

pMag and nMag are presented in the review context as a light-induced dimerization pair used to reconstitute split Cas9 in photoactivatable genome editing.

The anchor figure caption names pMag as one half of the light-induced dimerization pair used to reconstitute split Cas9 ... nMag as the partner to pMag.
Claim 155translational potentialsupports2016Source 22needs review

Optogenetic defibrillation could potentially be translated into humans to achieve nondamaging and pain-free termination of ventricular arrhythmia.

Claim 156applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 157applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 158applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 159applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 160applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 161applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 162applicationsupports2015Source 7needs review

Optical modulation for optogenetic assays can be obtained in a miniaturized 384-well plate format using the FLIPR instrument.

we sought to determine if this optical modulation can be obtained also in a miniaturized format, such as a 384-well plate, using the instrumentations normally dedicated to fluorescence analysis in High Throughput Screening (HTS) activities, such as for example the FLIPR (Fluorometric Imaging Plate Reader) instrument
plate format 384-well
Claim 163assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 164assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 165assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 166assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 167assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 168assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 169assay performancesupports2015Source 7needs review

Stable, robust, and miniaturized cellular assays can be developed using different optogenetic tools and modulated by FLIPR LEDs in a 384-well format.

stable, robust and miniaturized cellular assays can be developed using different optogenetic tools, and efficiently modulated by the FLIPR instrument LEDs in a 384-well format
plate format 384-well
Claim 170functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 171functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 172functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 173functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 174functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 175functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 176functional capabilitysupports2015Source 31needs review

Channelrhodopsin-2 can be used to control the number and frequency of action potentials.

Using the naturally occurring algal protein Channelrhodopsin-2 (ChR2), a rapidly gated light-sensitive cation channel, the number and frequency of action potentials can be controlled.
Claim 177modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 178modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 179modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 180modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 181modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 182modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 183modulation target pairingsupports2015Source 7needs review

bPAC adenylyl cyclase was used to modulate the HCN2 cyclic nucleotide gated channel in an optogenetic assay.

the HCN2 cyclic nucleotide gated (CNG) channel was modulated by the light activated bPAC adenylyl cyclase
Claim 184modulation target pairingsupports2015Source 7needs review

Channelrhodopsin-2 was used to modulate the CaV1.3 calcium channel in an optogenetic assay.

the CaV1.3 calcium channel was modulated by the light-activated Channelrhodopsin-2
Claim 185modulation target pairingsupports2015Source 7needs review

Channelrhodopsin-2 was used to modulate the CaV1.3 calcium channel in an optogenetic assay.

the CaV1.3 calcium channel was modulated by the light-activated Channelrhodopsin-2
Claim 186modulation target pairingsupports2015Source 7needs review

Channelrhodopsin-2 was used to modulate the CaV1.3 calcium channel in an optogenetic assay.

the CaV1.3 calcium channel was modulated by the light-activated Channelrhodopsin-2
Claim 187modulation target pairingsupports2015Source 7needs review

Channelrhodopsin-2 was used to modulate the CaV1.3 calcium channel in an optogenetic assay.

the CaV1.3 calcium channel was modulated by the light-activated Channelrhodopsin-2
Claim 188modulation target pairingsupports2015Source 7needs review

Channelrhodopsin-2 was used to modulate the CaV1.3 calcium channel in an optogenetic assay.

the CaV1.3 calcium channel was modulated by the light-activated Channelrhodopsin-2
Claim 189modulation target pairingsupports2015Source 7needs review

Channelrhodopsin-2 was used to modulate the CaV1.3 calcium channel in an optogenetic assay.

the CaV1.3 calcium channel was modulated by the light-activated Channelrhodopsin-2
Claim 190specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 191specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 192specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 193specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 194specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 195specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 196specificitysupports2015Source 31needs review

Channelrhodopsin-2 provides a way to manipulate a single type of neuron while affecting no others.

The ChR2 provides a way to manipulate a single type of neuron while affecting no others, an unprecedented specificity.
Claim 197tooling landscapesupports2015Source 13needs review

The review context highlights optogenetic and chemogenetic tools as major approaches for manipulating genetically defined amygdala populations in fear-circuit studies.

Claim 198application capabilitysupports2014Source 29needs review

ChR2 has been used to control neuronal activity in vitro and in vivo on short time scales and with exquisite anatomical precision.

ChR2 has been used by many groups to control neuronal activity, both in vitro and in vivo , on short time scales and with exquisite anatomical precision.
Claim 199application effectsupports2014Source 25needs review

Optogenetic stimulation of spiral ganglion neurons restored auditory activity in deaf mice.

Furthermore, optogenetic stimulation of SGNs restored auditory activity in deaf mice.
Claim 200astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 201astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 202astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 203astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 204astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 205astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 206astrocyte targeting applicationsupports2014Source 1needs review

Light-activated Gq protein-coupled opsins are described as a way to selectively activate astrocytes to explore the influence of gliotransmission on epileptic network function.

The influence of gliotransmission on epileptic network function is another topic of great interest that can be further explored by using light-activated Gq protein-coupled opsins for selective activation of astrocytes.
Claim 207broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 208broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 209broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 210broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 211broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 212broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 213broad capabilitysupports2014Source 1needs review

Channelrhodopsin-2, halorhodopsin, and archaerhodopsin-3 are presented as potent optogenetic candidates for controlling neuronal firing in models of epilepsy and for providing insights into neuronal network organization and synchronization.

The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), halorhodopsin (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization.
Claim 214combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 215combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 216combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 217combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 218combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 219combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 220combinatorial method usesupports2014Source 1needs review

The optogenetic toolbox can be combined with juxtacellular recording and two-photon guided whole-cell recording to help identify specific cortical and hippocampal neuron subtypes altered in epileptic networks.

The ever-growing optogenetic toolbox can also be combined with emerging techniques that have greatly expanded our ability to record specific subtypes of cortical and hippocampal neurons in awake behaving animals such as juxtacellular recording and two-photon guided whole-cell recording, to identify the specific subtypes of neurons that are altered in epileptic networks.
Claim 221engineering improvementsupports2014Source 25needs review

Virus-mediated expression of a more light-sensitive ChR2 variant in spiral ganglion neurons reduced the amount of light required for responses and allowed neuronal spiking up to 60 Hz.

Virus-mediated expression of a ChR2 variant with greater light sensitivity in SGNs reduced the amount of light required for responses and allowed neuronal spiking following stimulation up to 60 Hz.
neuronal spiking frequency 60 Hz
Claim 222mechanistic effectsupports2014Source 25needs review

Optogenetic stimulation of spiral ganglion neurons activated the auditory pathway.

Optogenetic stimulation of spiral ganglion neurons (SGNs) activated the auditory pathway, as demonstrated by recordings of single neuron and neuronal population responses.
Claim 223seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 224seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 225seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 226seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 227seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 228seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 229seizure suppression capabilitysupports2014Source 1needs review

Optogenetic tools allow rapid and reversible suppression of epileptic EEG activity upon photoactivation.

Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.
Claim 230selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 231selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 232selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 233selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 234selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 235selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 236selective cell type controlsupports2014Source 1needs review

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, including interneuron subclasses, to study activity patterns in distinct brain states and dissect roles in synchrony and seizures.

Opsins allow selective activation of excitatory neurons and inhibitory interneurons, or subclasses of interneurons, to study their activity patterns in distinct brain-states in vivo and to dissect their role in generation of synchrony and seizures.
Claim 237tool class inclusionsupports2014Source 29needs review

A light-activated transgene system is a more recently developed optogenetic tool discussed by the source.

and a light-activated transgene system.
Claim 238tool class inclusionsupports2014Source 29needs review

Opsin/G protein-coupled receptor chimeric molecules are more recently developed optogenetic tools discussed by the source.

In addition, we describe more recently developed tools such as opsin/G protein-coupled receptor chimeric molecules
Claim 239usage prevalencesupports2014Source 29needs review

ChR2 is the photosensitive protein most commonly employed in optogenetics.

We focus especially on the channelrhodopsin protein ChR2, the photosensitive protein most commonly employed in optogenetics.
Claim 240advantagesupports2013Source 21needs review

Optogenetic stimulation allows arbitrary stimulation of opsin-expressing brain regions, enabling brain mapping independent of behavior or sensory processing.

Claim 241advantage statementsupports2013Source 27needs review

The optogenetic seizure-like afterdischarge model was advantageous for reproducibility and artifact-free electrophysiological observations.

Claim 242application resultsupports2013Source 27needs review

Hippocampal photostimulation of ChR2-expressing rodents successfully induced seizure-like afterdischarges in both transgenic rats and wild-type rats transfected with AAV vectors carrying ChR2.

Claim 243application scopesupports2013Source 44needs review

With KENGE-tet-based optogenetic mice, in vivo manipulation of nonexcitable glial cells is possible in addition to neurons.

In addition to neurons, manipulations of the activities of nonexcitable glial cells in vivo have also proved possible.
Claim 244biological effectsupports2013Source 44needs review

A recent report using KENGE-tet found that selective optogenetic stimulation of glia can lead to glutamate release, synaptic plasticity, and accelerated cerebellar-modulated motor learning.

A recent report that used the KENGE-tet has shown that the selective optogenetic stimulation of glia can lead to the release of glutamate as a gliotransmitter, synaptic plasticity, and the acceleration of cerebellar-modulated motor learning.
Claim 245capabilitysupports2013Source 44needs review

Channelrhodopsin-2 can be genetically expressed in mammalian brain cells to allow optical control of cell activity.

channelrhodopsin-2, that are found in microorganisms can now be genetically expressed in mammalian brain cells, allowing experimenters to optically control cell activity at will
Claim 246compatibilitysupports2013Source 21needs review

Red-shifted organic voltage-sensitive dyes permit high temporal resolution imaging that is spectrally separated from Channelrhodopsin-2 activation.

Claim 247implementation supportsupports2013Source 26needs review

Long-term in vivo optogenetic studies in this review context rely on implantable optical-fiber strategies for light delivery.

Claim 248mechanistic observationsupports2013Source 27needs review

A single induced afterdischarge produced c-Fos evidence of neuronal activation across the entire hippocampus.

Claim 249mechanistic observationsupports2013Source 21needs review

VSD maps stimulated by ChR2 were dependent on intracortical synaptic activity and reflected circuits used for sensory processing.

Claim 250method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 251method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 252method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 253method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 254method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 255method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 256method demonstrationsupports2013Source 8needs review

The computational modeling technique was demonstrated using channelrhodopsin-2 and halorhodopsin as examples of optical activation and silencing mechanisms.

It was demonstrated on the example of a two classical mechanisms for cells optical activation and silencing: channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR).
Claim 257methodological emphasissupports2013Source 26needs review

Projection-specific optogenetic manipulation is presented as a central strategy for dissecting stress-related circuitry.

Claim 258method outputsupports2013Source 44needs review

KENGE-tet generated a repertoire of transgenic mice expressing a highly light-sensitive channelrhodopsin-2 mutant at levels sufficient to stimulate multiple cell types.

KENGE-tet method, which has generated a repertoire of transgenic mice that express levels of the highly light-sensitive channelrhodopsin-2 mutant that are sufficient to stimulate multiple cell types
Claim 259method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 260method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 261method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 262method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 263method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 264method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 265method presentationsupports2013Source 8needs review

The paper presents a generalised computational modeling technique for various optogenetic mechanisms implemented in the NEURON simulation environment.

Here we present a generalised computational modeling technique for various types of optogenetic mechanisms, which was implemented in the NEURON simulation environment.
Claim 266model developmentsupports2013Source 27needs review

The paper developed a novel in vivo optogenetic model of seizure-like afterdischarge in the rodent hippocampus.

Claim 267network analysis resultsupports2013Source 27needs review

Granger causality analysis of hippocampal LFPs showed bidirectional but asymmetric signal flow along the septo-temporal axis during seizure-like afterdischarges.

Claim 268parameter optimizationsupports2013Source 27needs review

Pulse frequencies of 10 and 20 Hz with a 0.05 duty ratio were optimal for afterdischarge induction.

duty ratio 0.05pulse frequency 10 Hzpulse frequency 20 Hz
Claim 269resolutionsupports2013Source 21needs review

Opsin-based activation allows investigation of connectivity with spatial resolution on the order of single neurons and temporal resolution on the order of milliseconds.

spatial resolution on the order of single neuronstemporal resolution on the order of milliseconds
Claim 270simulation findingsupports2013Source 8needs review

In the modeled layer 5 cortical pyramidal neuron, whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and can silence the cell even when driving input is present.

We show that whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and is able to silence the cell even when driving input is present.
Claim 271simulation findingsupports2013Source 8needs review

In the modeled layer 5 cortical pyramidal neuron, whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and can silence the cell even when driving input is present.

We show that whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and is able to silence the cell even when driving input is present.
Claim 272simulation findingsupports2013Source 8needs review

In the modeled layer 5 cortical pyramidal neuron, whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and can silence the cell even when driving input is present.

We show that whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and is able to silence the cell even when driving input is present.
Claim 273simulation findingsupports2013Source 8needs review

In the modeled layer 5 cortical pyramidal neuron, whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and can silence the cell even when driving input is present.

We show that whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and is able to silence the cell even when driving input is present.
Claim 274simulation findingsupports2013Source 8needs review

In the modeled layer 5 cortical pyramidal neuron, whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and can silence the cell even when driving input is present.

We show that whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and is able to silence the cell even when driving input is present.
Claim 275simulation findingsupports2013Source 8needs review

In the modeled layer 5 cortical pyramidal neuron, whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and can silence the cell even when driving input is present.

We show that whole-cell illumination of halorhodopsin most effectively hyperpolarizes the neuron and is able to silence the cell even when driving input is present.
Claim 276simulation findingsupports2013Source 8needs review

When channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the neural response is modulated toward depolarization.

However, when channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the response is modulated with a balance towards depolarization.
Claim 277simulation findingsupports2013Source 8needs review

When channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the neural response is modulated toward depolarization.

However, when channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the response is modulated with a balance towards depolarization.
Claim 278simulation findingsupports2013Source 8needs review

When channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the neural response is modulated toward depolarization.

However, when channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the response is modulated with a balance towards depolarization.
Claim 279simulation findingsupports2013Source 8needs review

When channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the neural response is modulated toward depolarization.

However, when channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the response is modulated with a balance towards depolarization.
Claim 280simulation findingsupports2013Source 8needs review

When channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the neural response is modulated toward depolarization.

However, when channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the response is modulated with a balance towards depolarization.
Claim 281simulation findingsupports2013Source 8needs review

When channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the neural response is modulated toward depolarization.

However, when channelrhodopsin-2 and halorhodopsin are concurrently active, the relative location of each illumination determines whether the response is modulated with a balance towards depolarization.
Claim 282state modelsupports2013Source 27needs review

State-space analysis of causality and coherence identified three discrete states of seizure-like afterdischarge: resting, initiation with dominant septal-to-temporal causality, and termination with dominant temporal-to-septal causality.

Claim 283targeting strategysupports2013Source 26needs review

The review discusses promoter-based targeting such as CaMKIIα to enrich opsin delivery to selected neuronal populations.

Claim 284toolkit summarysupports2013Source 26needs review

The review discusses both excitatory and inhibitory optogenetic actuators for causal manipulation of stress-related neural circuits.

Claim 285usagesupports2013Source 33needs review

Channelrhodopsin-2 was used as an optogenetic tag to identify PV+ and PV- neurons in vivo in transgenic mice.

We used channelrhodopsin-2 (ChR2) as an optogenetic tag to identify PV+ and PV- neurons in vivo in transgenic mice.
Claim 286behavioral effectsupports2012Source 18needs review

A single 200 ms light pulse delivered after each self-initiated nose poke was sufficient to cause operant reinforcement.

When a single light pulse followed each self-initiated nose poke, it was sufficient in itself to cause operant reinforcement.
Claim 287behavioral effectsupports2012Source 18needs review

Optical stimulation of genetically targeted VTA dopamine neurons increased locomotion and contralateral rotations when delivered according to a predetermined pattern in separate sessions.

when optical stimulation was delivered in separate sessions according to a predetermined pattern, it increased locomotion and contralateral rotations
Claim 288construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 289construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 290construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 291construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 292construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 293construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 294construct functionsupports2012Source 37needs review

A bicistronic expression cassette with GFP helps identify the correct expression pattern.

A bicistronic expression cassette with GFP helps to identify the correct expression pattern
Claim 295correlationsupports2012Source 18needs review

Optically induced operant and locomotor behaviors were tightly correlated with the number of VTA dopamine neurons expressing ChR2.

All three of the optically induced operant and locomotor behaviors were tightly correlated with the number of VTA dopamine neurons that expressed ChR2
Claim 296dependencysupports2012Source 37needs review

Success of the conditional single-neuron Channelrhodopsin-2 expression method depends on precise knowledge of individual promoter expression patterns and on relative expression levels of recombinase and Channelrhodopsin-2.

Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2
Claim 297dependencysupports2012Source 37needs review

Success of the conditional single-neuron Channelrhodopsin-2 expression method depends on precise knowledge of individual promoter expression patterns and on relative expression levels of recombinase and Channelrhodopsin-2.

Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2
Claim 298dependencysupports2012Source 37needs review

Success of the conditional single-neuron Channelrhodopsin-2 expression method depends on precise knowledge of individual promoter expression patterns and on relative expression levels of recombinase and Channelrhodopsin-2.

Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2
Claim 299dependencysupports2012Source 37needs review

Success of the conditional single-neuron Channelrhodopsin-2 expression method depends on precise knowledge of individual promoter expression patterns and on relative expression levels of recombinase and Channelrhodopsin-2.

Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2
Claim 300dependencysupports2012Source 37needs review

Success of the conditional single-neuron Channelrhodopsin-2 expression method depends on precise knowledge of individual promoter expression patterns and on relative expression levels of recombinase and Channelrhodopsin-2.

Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2
Claim 301dependencysupports2012Source 37needs review

Success of the conditional single-neuron Channelrhodopsin-2 expression method depends on precise knowledge of individual promoter expression patterns and on relative expression levels of recombinase and Channelrhodopsin-2.

Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2
Claim 302expression resultsupports2012Source 37needs review

The authors show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons.

Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons
Claim 303expression resultsupports2012Source 37needs review

The authors show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons.

Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons
Claim 304expression resultsupports2012Source 37needs review

The authors show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons.

Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons
Claim 305expression resultsupports2012Source 37needs review

The authors show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons.

Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons
Claim 306expression resultsupports2012Source 37needs review

The authors show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons.

Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons
Claim 307expression resultsupports2012Source 37needs review

The authors show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons.

Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons
Claim 308mechanismsupports2012Source 28needs review

ChR2 responds to blue light to induce neuronal firing via cation influx.

ChR2 responds to blue light to induce neuronal firing via cation influx
Claim 309mechanismsupports2012Source 28needs review

NpHR responds to yellow light to inhibit neuronal activity via chloride influx.

NpHR responds to yellow light to inhibit neuronal activity via Cl- influx
Claim 310method applicationsupports2012Source 37needs review

The authors used Cre or FLP recombinases with conditional Channelrhodopsin-2 expression at the intersection of two promoter expression domains to restrict expression to the cell of interest.

we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only
Claim 311method applicationsupports2012Source 37needs review

The authors used Cre or FLP recombinases with conditional Channelrhodopsin-2 expression at the intersection of two promoter expression domains to restrict expression to the cell of interest.

we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only
Claim 312method applicationsupports2012Source 37needs review

The authors used Cre or FLP recombinases with conditional Channelrhodopsin-2 expression at the intersection of two promoter expression domains to restrict expression to the cell of interest.

we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only
Claim 313method applicationsupports2012Source 37needs review

The authors used Cre or FLP recombinases with conditional Channelrhodopsin-2 expression at the intersection of two promoter expression domains to restrict expression to the cell of interest.

we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only
Claim 314method applicationsupports2012Source 37needs review

The authors used Cre or FLP recombinases with conditional Channelrhodopsin-2 expression at the intersection of two promoter expression domains to restrict expression to the cell of interest.

we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only
Claim 315method applicationsupports2012Source 37needs review

The authors used Cre or FLP recombinases with conditional Channelrhodopsin-2 expression at the intersection of two promoter expression domains to restrict expression to the cell of interest.

we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only
Claim 316methodology summarysupports2012Source 10needs review

In source material connected to this review, ChR2 and NpHR are explicit optogenetic actuators used to interrogate dopamine circuits, while FSCV is an explicit paired measurement method for dopamine release dynamics.

Explicitly supported related components/tools include ChR2, NpHR, fast-scan cyclic voltammetry (FSCV), TH-Cre, DAT-Cre, and recombinase-driver rat lines.
Claim 317scope summarysupports2012Source 23needs review

The source synthesizes early optogenetic circuit-dissection studies of emotional valence and motivated behaviors, emphasizing ChR2, NpHR/eNpHR3.0, and projection-specific manipulations.

The review synthesizes early optogenetic circuit-dissection work across mesolimbic dopamine, striatum, hypothalamus, and amygdala, emphasizing tools such as ChR2 and NpHR/eNpHR3.0 and projection-specific manipulations.
Claim 318sufficiencysupports2012Source 18needs review

A 200 ms optogenetic activation of genetically targeted VTA dopamine neurons was sufficient to mimic transient natural reward-associated dopamine activation.

We mimicked the transient activation of dopamine neurons that occurs in response to natural reward by applying a light pulse of 200 ms in VTA.
light pulse duration 200 ms
Claim 319targeting summarysupports2012Source 10needs review

Selective genetic targeting is a central enabling component in dopamine optogenetics, with TH-Cre, DAT-Cre, and recombinase-driver rat lines identified as relevant targeting tools in source material connected to this review.

Explicitly supported related components/tools include ChR2, NpHR, fast-scan cyclic voltammetry (FSCV), TH-Cre, DAT-Cre, and recombinase-driver rat lines.
Claim 320tool rolesupports2012Source 24needs review

Channelrhodopsin-2 is presented in the supplied evidence scaffold as an optogenetic actuator enabling causal circuit perturbation in studies aligned to this review's scope.

Claim 321capabilitysupports2011Source 40needs review

Channelrhodopsin-2 and PAC α expressed in individual olfactory receptor neurons of Drosophila larvae allow stimulation of individual receptor neurons by light.

Both channelrhodopsin-2 and the photosensitive adenylyl cyclase PAC α in individual olfactory receptor neurons (ORNs) of the olfactory system of Drosophila larvae allows stimulating individual receptor neurons by light.
Claim 322comparison summarysupports2011Source 36needs review

The reviewed remote-control tools differ in effect direction, onset and offset kinetics, spatial resolution, and invasiveness.

Claim 323limitation summarysupports2011Source 36needs review

None of the reviewed neuronal remote-control tools is perfect, and each has advantages and disadvantages.

Claim 324mechanism summarysupports2011Source 36needs review

The reviewed tools use light, peptides, and small molecules to primarily activate ion channels and GPCRs, thereby activating or inhibiting neuronal firing.

Claim 325review scope summarysupports2011Source 36needs review

Remote bidirectional manipulation of neuronal electrical and chemical signaling with high spatiotemporal precision is presented as an ideal approach for linking neural activity to behavior.

Claim 326comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 327comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 328comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 329comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 330comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 331comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 332comparative review scopesupports2010Source 3needs review

The review compares channelrhodopsin variants using seven key properties that influence their effectiveness as research tools: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response, and membrane trafficking.

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.
Claim 333engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 334engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 335engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 336engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 337engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 338engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 339engineering summarysupports2010Source 3needs review

Chimeragenesis, mutagenesis, and bioinformatic approaches have introduced additional channelrhodopsin variants including ChR2/H134R, ChETA, VChR1, VChR2, ChR2/C128X/D156A, ChD, ChEF, and I170V.

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).
Claim 340functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 341functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 342functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 343functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 344functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 345functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 346functional rolesupports2010Source 3needs review

Channelrhodopsins are light-activated channels from algae that function as fast sensors to visible light for phototaxis.

Channelrhodopsins (ChRs) are light-activated channels from algae that provide these organisms with fast sensors to visible light for phototaxis.
Claim 347review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 348review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 349review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 350review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 351review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 352review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 353review conclusion scopesupports2010Source 3needs review

The review summarizes valuable qualities and deficits of each channelrhodopsin variant and discusses optimal uses and potential future improvements of channelrhodopsins as optogenetic tools.

Using this information, valuable qualities and deficits of each ChR variant are summarized. Optimal uses and potential future improvements of ChRs as optogenetic tools are also discussed.
Claim 354tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 355tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 356tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 357tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 358tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 359tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 360tool usesupports2010Source 3needs review

Channelrhodopsin-2 has been used as a research tool to depolarize membranes of excitable cells with light.

Since its discovery, channelrhodopsin-2 (ChR2) has been used as a research tool to depolarize membranes of excitable cells with light.
Claim 361expression targetingsupports2009Source 42needs review

The study used a transgenic rat expressing ChR2 specifically in retinal ganglion cells under the regulation of a Thy-1.2 promoter.

by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter
Claim 362expression targetingsupports2009Source 42needs review

The study used a transgenic rat expressing ChR2 specifically in retinal ganglion cells under the regulation of a Thy-1.2 promoter.

by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter
Claim 363expression targetingsupports2009Source 42needs review

The study used a transgenic rat expressing ChR2 specifically in retinal ganglion cells under the regulation of a Thy-1.2 promoter.

by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter
Claim 364expression targetingsupports2009Source 42needs review

The study used a transgenic rat expressing ChR2 specifically in retinal ganglion cells under the regulation of a Thy-1.2 promoter.

by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter
Claim 365expression targetingsupports2009Source 42needs review

The study used a transgenic rat expressing ChR2 specifically in retinal ganglion cells under the regulation of a Thy-1.2 promoter.

by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter
Claim 366expression targetingsupports2009Source 42needs review

The study used a transgenic rat expressing ChR2 specifically in retinal ganglion cells under the regulation of a Thy-1.2 promoter.

by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter
Claim 367functional effectsupports2009Source 42needs review

After degeneration of native photoreceptors, transgenic rats showed enhanced optomotor contrast sensitivity for low-spatial-frequency visual stimuli compared with wild-type-like baseline similarity.

Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors.
Claim 368functional effectsupports2009Source 42needs review

After degeneration of native photoreceptors, transgenic rats showed enhanced optomotor contrast sensitivity for low-spatial-frequency visual stimuli compared with wild-type-like baseline similarity.

Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors.
Claim 369functional effectsupports2009Source 42needs review

After degeneration of native photoreceptors, transgenic rats showed enhanced optomotor contrast sensitivity for low-spatial-frequency visual stimuli compared with wild-type-like baseline similarity.

Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors.
Claim 370functional effectsupports2009Source 42needs review

After degeneration of native photoreceptors, transgenic rats showed enhanced optomotor contrast sensitivity for low-spatial-frequency visual stimuli compared with wild-type-like baseline similarity.

Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors.
Claim 371functional effectsupports2009Source 42needs review

After degeneration of native photoreceptors, transgenic rats showed enhanced optomotor contrast sensitivity for low-spatial-frequency visual stimuli compared with wild-type-like baseline similarity.

Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors.
Claim 372functional effectsupports2009Source 42needs review

After degeneration of native photoreceptors, transgenic rats showed enhanced optomotor contrast sensitivity for low-spatial-frequency visual stimuli compared with wild-type-like baseline similarity.

Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors.
Claim 373interpretationsupports2009Source 42needs review

The results suggest that visual signals derived from ChR2-expressing retinal ganglion cells were reinterpreted by the brain to form behavior-related vision.

This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.
Claim 374interpretationsupports2009Source 42needs review

The results suggest that visual signals derived from ChR2-expressing retinal ganglion cells were reinterpreted by the brain to form behavior-related vision.

This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.
Claim 375interpretationsupports2009Source 42needs review

The results suggest that visual signals derived from ChR2-expressing retinal ganglion cells were reinterpreted by the brain to form behavior-related vision.

This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.
Claim 376interpretationsupports2009Source 42needs review

The results suggest that visual signals derived from ChR2-expressing retinal ganglion cells were reinterpreted by the brain to form behavior-related vision.

This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.
Claim 377interpretationsupports2009Source 42needs review

The results suggest that visual signals derived from ChR2-expressing retinal ganglion cells were reinterpreted by the brain to form behavior-related vision.

This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.
Claim 378interpretationsupports2009Source 42needs review

The results suggest that visual signals derived from ChR2-expressing retinal ganglion cells were reinterpreted by the brain to form behavior-related vision.

This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.
Claim 379potential applicationsupports2009Source 42needs review

Channelrhodopsin-2 is described as a potentially useful optogenetic tool for restoring vision in photoreceptor degeneration.

Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa.
Claim 380potential applicationsupports2009Source 42needs review

Channelrhodopsin-2 is described as a potentially useful optogenetic tool for restoring vision in photoreceptor degeneration.

Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa.
Claim 381potential applicationsupports2009Source 42needs review

Channelrhodopsin-2 is described as a potentially useful optogenetic tool for restoring vision in photoreceptor degeneration.

Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa.
Claim 382potential applicationsupports2009Source 42needs review

Channelrhodopsin-2 is described as a potentially useful optogenetic tool for restoring vision in photoreceptor degeneration.

Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa.
Claim 383potential applicationsupports2009Source 42needs review

Channelrhodopsin-2 is described as a potentially useful optogenetic tool for restoring vision in photoreceptor degeneration.

Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa.
Claim 384potential applicationsupports2009Source 42needs review

Channelrhodopsin-2 is described as a potentially useful optogenetic tool for restoring vision in photoreceptor degeneration.

Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa.

Approval Evidence

44 sources81 linked approval claimsfirst-pass slugs channel-rhodopsin-2, channelrhodopsin-2, channelrhodopsin-2-chr2, channelrhodopsin-2-chr2-hippocampal-seizure-induction-model, channelrhodopsin-2-optogenetic-tag, chr2, flex-channelrhodopsin2
we demonstrate successful Cre-dependent recombination to selectively express channelrhodopsin-2 in Sp5C projection neurons

Source:

This review traces the evolution of opsins in optogenetic therapies, highlighting advancements from early research on channelrhodopsin-2 (ChR2) to engineered variants addressing key limitations.

Source:

Since the introduction of Channelrhodopsin-2 and phytochrome-based switches nearly 20 years ago

Source:

mouse hearts expressing channelrhodopsin-2 (ChR2)

Source:

Since the first demonstration of the millisecond neuromodulation ability of the channelrhodopsin-2 (ChR2)...

Source:

These tools can offer low-energy and localized approaches due to the use of the transgenically expressed light gated cation channel Channelrhodopsin-2 (ChR2).

Source:

Our first demonstration of the feasibility of such an approach involved expressing ChR2 in the retinal ganglion cells of blind mice; since then, optogenetic vision restoration has been demonstrated by using a variety of optogenetic tools, especially microbial channelrhodopsins (ChRs).

Source:

Several explicitly supported related method/component names surfaced from the literature, including PACT, PARS, RIMS, electrophoretic tissue clearing (ETC), and Channelrhodopsin-2 (ChR2).

Source:

The supplied web research summary lists Channelrhodopsin-2 (ChR2) as an explicitly supported related tool/component and a canonical optogenetic actuator relevant to the review's broader modality coverage.

Source:

At the system-level, this requires construction of transgenic mice expressing ChR2 in their cardiomyocytes... ChR2-expressing cardiomyocytes show normal baseline and active excitable membrane and Ca2+ signaling properties and are sensitive even to ~1 ms light pulses.

Source:

Channelrhodopsin is present in the source metadata concepts, and the web research summary lists Channelrhodopsin-2 (ChR2) as an explicitly supported component/tool name across sources connected to the review.

Source:

The paper reports ex vivo optogenetic pacing in ChR2 hearts.

Source:

genetic access demosupports

Cre-dependent recombination successfully enabled selective channelrhodopsin-2 expression in Sp5C projection neurons.

Source:

adoption barriersupports

Plant dependence on light and the absence of retinal were barriers to establishing plant optogenetics until recent progress overcame these difficulties.

For a long time, the dependence of plant growth on light and the absence of retinal, the rhodopsin chromophore, prevented the establishment of plant optogenetics until recent progress overcame these difficulties.

Source:

applicationsupports

A combination of ElectroFluor 730p, X-Rhod-1, and ChR2 in mouse hearts enables simultaneous monitoring of transmembrane potential and cytosolic calcium while performing optogenetic manipulation with minimal crosstalk.

We here present a novel approach to simultaneously monitor transmembrane potential and cytosolic calcium, while also performing optogenetic manipulation. For this, we used the novel voltage-sensitive dye ElectroFluor 730p and the cytosolic calcium indicator X-Rhod-1 in mouse hearts expressing channelrhodopsin-2 (ChR2). By exploiting the isosbestic point of ElectroFluor 730p and avoiding the ChR2 activation spectrum, we here introduce a novel optical imaging and manipulation approach with minimal crosstalk.

Source:

capability summarysupports

Light input can be switched on or off and tuned in intensity and duration to provide noninvasive, spatiotemporally resolved control of cellular processes.

Light can be turned on or off, and adjusting its intensity and duration allows optogenetic fine-tuning of cellular processes in a noninvasive and spatiotemporally resolved manner.

Source:

field adoption summarysupports

Optogenetic tools have been widely successful in multiple model organisms but have been used relatively rarely in plants.

optogenetic tools have been applied in a variety of model organisms with enormous success, but rarely in plants

Source:

review scope summarysupports

Optogenetics uses natural or engineered photoreceptors in transgenic organisms to manipulate biological activities with light.

Optogenetics is a technique employing natural or genetically engineered photoreceptors in transgene organisms to manipulate biological activities with light.

Source:

capability summarysupports

Channelrhodopsin-2 is described as enabling millisecond neuromodulation.

Since the first demonstration of the millisecond neuromodulation ability of the channelrhodopsin-2 (ChR2)

Source:

field progress summarysupports

Optogenetic technology progressed rapidly in basic life science research, especially neurobiology, after the first demonstration of ChR2-based millisecond neuromodulation.

the application of optogenetic technology in basic life science research has been rapidly progressed, especially in neurobiology

Source:

advantage summarysupports

Channelrhodopsin-2-based optogenetic approaches can offer low-energy and localized control.

Source:

foundational usesupports

ChR2 expression in retinal ganglion cells of blind mice served as an early feasibility demonstration for optogenetic vision restoration.

Our first demonstration of the feasibility of such an approach involved expressing ChR2 in the retinal ganglion cells of blind mice

Source:

application resultsupports

The paper reports ex vivo optogenetic pacing in ChR2 hearts.

Source:

application summarysupports

In cardiac physiology, optogenetics has mainly used optically controlled depolarizing ion channels to control heart rate and for optogenetic defibrillation.

Source:

compatibility summarysupports

ChR2-expressing cardiomyocytes show normal baseline and active excitable membrane and Ca2+ signaling properties and are sensitive even to approximately 1 ms light pulses.

Source:

delivery requirementsupports

Expression of the chosen optogenetic tool in cardiac cells requires gene introduction by viral transduction or coupling via spark cells at the single-cell level, and transgenic expression or in vivo adenoviral delivery at system level.

Source:

toolkit landscapesupports

Named platforms aligned with the review's scope include LiGluR, LiGluN, LimGluR, optogating, ChR2, and Arch.

Primary papers for specific photoswitchable receptor platforms explicitly named in or strongly aligned with the review (LiGluR, LiGluN, LimGluR, optogating of P2X2)... Channelrhodopsin-2 (ChR2)... Arch.

Source:

comparative structural inferencesupports

Comparison with the ChR2 C128T structure reveals a direct connection of the DC gate to the central gate and suggests that the gating mechanism is affected by subtle tuning of Schiff base interactions.

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.

Source:

structural mechanismsupports

In ChR2, the retinal Schiff base controls and synchronizes three gates that separate the cavities.

Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities.

Source:

structural mechanismsupports

The ChR2 structure reveals two intracellular cavities and two extracellular cavities connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues.

Source:

structural mechanismsupports

The DC gate in ChR2 comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base.

Source:

structural observationsupports

High-resolution structures were presented for ChR2 and the ChR2 C128T mutant.

We present high-resolution structures of ChR2 and the C128T mutant

Source:

Comparisons

Source-backed strengths

The supplied evidence states that ChR2 has been used as a research tool to depolarize membranes of excitable cells with light and is a prominent example for light-dependent activation of electrically excitable cells. Its use across optogenetics literature over nearly 20 years and the existence of structural work on ion conduction support that it is a well-established tool.

Source:

Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base's interactions.

Source:

In this review, the seven following key properties of ChRs that have significant influences on their effectiveness as research tools are examined: conductance, selectivity, kinetics, desensitization, light sensitivity, spectral response and membrane trafficking.

Source:

Subsequent chimeragenesis, mutagenesis and bioinformatic approaches have introduced additional ChR variants, such as channelrhodopsin-2 with H134R mutation (ChR2/H134R), channelrhodopsin-2 with E123T mutation (ChETA), Volvox carteri channelrhodopsin-1 (VChR1), Volvox carteri channelrhodopsin-2 (VChR2), channelrhodopsin-2 with C128 or D156A mutations (ChR2/C128X/D156A), chimera D (ChD), chimera EF (ChEF) and chimera EF with I170V mutation (I170V).

Ranked Citations

  1. 1.

    Extracted from this source document. Seeded from load plan for claim cl1.

  2. 2.

    Extracted from this source document.

  3. 3.
    StructuralSource 3Experimental Physiology2010Claim 326Claim 327Claim 328

    Seeded from load plan for claim cl2. Extracted from this source document.

  4. 4.
    StructuralSource 4Frontiers in Physiology2021Claim 51Claim 53Claim 54

    Seeded from load plan for claim cl2. Extracted from this source document.

  5. 5.
    StructuralSource 5Frontiers in Neuroscience2022Claim 49Claim 50

    Seeded from load plan for claim cl_1. Extracted from this source document.

  6. 6.
    StructuralSource 6Frontiers in Systems Neuroscience2016Claim 126Claim 127Claim 128

    Seeded from load plan for claim cl2. Extracted from this source document.

  7. 7.
    StructuralSource 7Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE2015Claim 156Claim 157Claim 158

    Extracted from this source document.

  8. 8.

    Extracted from this source document.

  9. 9.
    StructuralSource 9Nature2012

    Extracted from this source document.

  10. 10.
    StructuralSource 10Brain Research2012Claim 316Claim 319

    Extracted from this source document.

  11. 11.

    Extracted from this source document.

  12. 12.

    Extracted from this source document.

  13. 13.
    StructuralSource 13Neuroscience2015Claim 197

    Extracted from this source document. Seeded from load plan for claim cl2.

  14. 14.
    StructuralSource 14Cell and Tissue Research2020Claim 55Claim 56Claim 57

    Extracted from this source document.

  15. 15.
    StructuralSource 15Nature reviews. Neuroscience2019Claim 70Claim 75

    Extracted from this source document.

  16. 16.
    StructuralSource 16Brain stimulation2016Claim 153

    Extracted from this source document.

  17. 17.
    StructuralSource 17Annual Review of Plant Biology2023Claim 12Claim 13Claim 14

    Extracted from this source document. Seeded from load plan for claim cl1.

  18. 18.

    Extracted from this source document. Seeded from load plan for claim c2.

  19. 19.
    StructuralSource 19Advances in experimental medicine and biology2021Claim 52

    Extracted from this source document. Seeded from load plan for claim cl2.

  20. 20.
    StructuralSource 20Proceedings of the National Academy of Sciences2016Claim 136Claim 138Claim 149

    Extracted from this source document. Seeded from load plan for claim c1.

  21. 21.
    StructuralSource 21Frontiers in Neuroscience2013Claim 240Claim 246Claim 249

    Extracted from this source document.

  22. 22.
    StructuralSource 22Journal of Clinical Investigation2016Claim 125Claim 137Claim 139

    Seeded from load plan for claim c1. Seeded from load plan for claim c5. Extracted from this source document.

  23. 23.
    StructuralSource 23DSpace@MIT (Massachusetts Institute of Technology)2012Claim 317

    Extracted from this source document.

  24. 24.
    StructuralSource 24Brain Research2012Claim 320

    Extracted from this source document.

  25. 25.
    StructuralSource 25Journal of Clinical Investigation2014Claim 199Claim 221Claim 222

    Extracted from this source document. Seeded from load plan for claim c2.

  26. 26.
    StructuralSource 26Behavioural Brain Research2013Claim 247Claim 257Claim 283

    Extracted from this source document.

  27. 27.

    Extracted from this source document. Seeded from load plan for claim c1.

  28. 28.
    StructuralSource 28Japanese Journal of Animal Psychology2012Claim 308Claim 309

    Extracted from this source document.

  29. 29.
    StructuralSource 29International Journal of Photoenergy2014Claim 198Claim 237Claim 238

    Extracted from this source document.

  30. 30.
    StructuralSource 30Biophysical Journal2016Claim 150Claim 151Claim 152

    Extracted from this source document.

  31. 31.
    StructuralSource 31Journal of Life Science2015Claim 170Claim 171Claim 172

    Extracted from this source document.

  32. 32.
    StructuralSource 32Addiction Biology2011

    Extracted from this source document.

  33. 33.
    StructuralSource 33Journal of Neuroscience2013Claim 285

    Extracted from this source document.

  34. 34.
    StructuralSource 34Frontiers in Physiology2019Claim 59Claim 63Claim 64

    Extracted from this source document. Seeded from load plan for claim cl_4.

  35. 35.
    StructuralSource 35MED2023Claim 19

    Extracted from this source document.

  36. 36.
    StructuralSource 36Pharmacological Reviews2011Claim 322Claim 323Claim 324

    Seeded from load plan for claim cl2. Extracted from this source document.

  37. 37.

    Extracted from this source document.

  38. 38.

    Seeded from load plan for claim c2.

  39. 39.
    StructuralSource 39Journal of Neuroscience2012

    Extracted from this source document.

  40. 40.
    StructuralSource 40Frontiers in Neuroscience2011Claim 321

    Extracted from this source document.

  41. 41.
    StructuralSource 41Neuroscience Letters2019Claim 66

    Extracted from this source document.

  42. 42.

    Extracted from this source document.

  43. 43.
    StructuralSource 43Nature Communications2019Claim 60Claim 61Claim 62

    Extracted from this source document.

  44. 44.

    Extracted from this source document.